Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...
Read Full NewsAvadel's REVITALYZ trial for Lumryz in idiopathic hypersomnia shows promise, potentially offering a new treatment option for this underserved condition.
NeurologyLive® provided in-depth coverage of conferences in 2025, highlighting advancements in diagnostics, treatments, and multidisciplinary care across multiple neurological conditions.
Ophthalmology in 2025: Year in Review
Increases in Physician Attrition Rates Could Worsen Shortages
Hormonal Disorders in 2025: Year in Review
1.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
2.
Skinny melanoma incidence is associated with vitamin D deficiency.
3.
What Dolph Lundgren's journey from terminal diagnosis to 'cancer free' can tell us about cancer care
4.
Why preventive mastectomy isn't offered to everyone at risk
5.
Long Wait Times on the Other Side of the Pond: King Charles' Cancer Diagnosis.
1.
Uncovering the Mysteries of Breast Cancer: The Journey to a Cure
2.
Autophagy: A Double-Edged Sword in Cancer Development, Immune Evasion, and Drug Resistance
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
Understanding Pancreatic Cancer: Symptoms, Causes and Risk Factors
5.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge